-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
X4 Pharmaceuticals, Inc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2016 to 2023.
- X4 Pharmaceuticals, Inc Net Cash Provided by (Used in) Operating Activities for the quarter ending June 30, 2024 was -$63.9M, a 33.4% decline year-over-year.
- X4 Pharmaceuticals, Inc Net Cash Provided by (Used in) Operating Activities for the twelve months ending June 30, 2024 was -$120M.
- X4 Pharmaceuticals, Inc annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$96.5M, a 25.2% decline from 2022.
- X4 Pharmaceuticals, Inc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$77.1M, a 8.74% decline from 2021.
- X4 Pharmaceuticals, Inc annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$70.9M, a 20.6% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)